O. Klungel

First name
Middle name
Last name
Abbing-Karahagopian, V., Kurz, X., de Vries, F., van Staa, T. P., Alvarez, Y., Hesse, U., et al. (2014). Bridging differences in outcomes of pharmacoepidemiological studies: design and first results of the PROTECT project. Curr Clin Pharmacol.
Abbing-Karahagopian, V., Huerta, C., Souverein, P. C., de Abajo, F., Leufkens, H. G., Slattery, J., et al. (2014). Antidepressant prescribing in five European countries: application of common definitions to assess the prevalence, clinical observations, and methodological implications. Eur J Clin Pharmacol. http://doi.org/10.1007/s00228-014-1676-z
van den Ham, H. A., Klungel, O. H., Singer, D. E., Leufkens, H. G., & van Staa, T. P. (2015). Comparative Performance of ATRIA, CHADS2, and CHA2DS2-VASc Risk Scores Predicting Stroke in Patients With Atrial Fibrillation: Results From a National Primary Care Database. J Am Coll Cardiol. http://doi.org/10.1016/j.jacc.2015.08.033
Wing, K., Bhaskaran, K., Smeeth, L., van Staa, T. P., Klungel, O. H., Reynolds, R. F., & Douglas, I. (2016). Optimising case detection within UK electronic health records: use of multiple linked databases for detecting liver injury. BMJ Open. http://doi.org/10.1136/bmjopen-2016-012102
Requena, G., Huerta, C., Gardarsdottir, H., Logie, J., Gonzalez-Gonzalez, R., Abbing-Karahagopian, V., et al. (2016). Hip/femur fractures associated with the use of benzodiazepines (anxiolytics, hypnotics and related drugs): a methodological approach to assess consistencies across databases from the PROTECT-EU project. Pharmacoepidemiol Drug Saf. http://doi.org/10.1002/pds.3816
Huerta, C., Abbing-Karahagopian, V., Requena, G., Oliva, B., Alvarez, Y., Gardarsdottir, H., et al. (2016). Exposure to benzodiazepines (anxiolytics, hypnotics and related drugs) in seven European electronic healthcare databases: a cross-national descriptive study from the PROTECT-EU Project. Pharmacoepidemiol Drug Saf. http://doi.org/10.1002/pds.3825
Wing, K., Bhaskaran, K., Pealing, L., Root, A., Smeeth, L., van Staa, T. P., et al. (2017). Quantification of the risk of liver injury associated with flucloxacillin: a UK population-based cohort study. J Antimicrob Chemother. http://doi.org/10.1093/jac/dkx183
De Jong, H. J. I., van Staa, T. P., Lalmohamed, A., de Vries, F., Vandebriel, R. J., Van Loveren, H., et al. (2017). Pattern of risks of systemic lupus erythematosus among statin users: a population-based cohort study. Ann Rheum Dis. http://doi.org/10.1136/annrheumdis-2016-210936
Ankarfeldt, M. Z., Thorsted, B. L., Groenwold, R. H., Adalsteinsson, E., Ali, M. S., & Klungel, O. H. (2017). Assessment of channeling bias among initiators of glucose-lowering drugs: A UK cohort study. Clin Epidemiol. http://doi.org/10.2147/clep.s124054
van Dalem, J., Brouwers, M., Stehouwer, C. D. A., Krings, A., Klungel, O. H., Driessen, J. H. M., et al. (2018). Risk of a first-ever acute myocardial infarction and all-cause mortality with sulphonylurea treatment: A population-based cohort study. Diabetes Obes Metab. http://doi.org/10.1111/dom.13168